Position in ALNY
as of Jun 30, 2026
· filed Aug 10, 2026
Position Value
$702,905
-$333,733 QoQ
Shares Held
2,335
-45.3% QoQ
Ownership
0.002%
of shares outstanding
% of Portfolio
0.11%
of 13F equity value
Holder Rank
#442
of 784 holders
Holding Since
Sep 2022
4 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in ALNY Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026Machina Capital S.A.S. holds $13,316,412 across 9 Biotechnology names. ALNY ranks #7 (5.3% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
8,966 | $4,453,681 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
3,827 | $2,386,287 | |
| 3 | RPRX |
Royalty Pharma plc
|
30,050 | $1,684,903 | |
| 4 | RVMD |
Revolution Medicines, Inc.
|
7,540 | $1,412,091 | |
| 5 | ROIV |
Roivant Sciences Ltd.
|
29,460 | $1,042,589 | |
| 6 | SMMT |
Summit Therapeutics Inc.
|
54,875 | $799,528 | |
| 7 | ALNY |
Alnylam Pharmaceuticals, Inc.
This page
|
2,335 | $702,905 | |
| 8 | EXEL |
Exelixis, Inc.
|
10,761 | $585,506 |
All Filings in ALNY
Export CSV
4 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $702,905 | 2,335 | Shares | Sole | 2026-08-10 | |
| 2024-06-30 | $1,036,638 | 4,266 | Shares | Sole | 2024-08-09 | |
| 2023-06-30 | $251,480 | 1,324 | Shares | Sole | 2023-08-08 | |
| 2022-09-30 | $343,674 | 1,717 | Shares | Sole | 2022-11-10 | |
| No filing history on record for this holder in this stock. | ||||||